drugset / Trial / NCT05604599
Intranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS
RandomizedParallel-groupTriple-blindPrevention
Summary
Intranasal dexmedetomidine provided good pharmacokinetic profile. However, intravenous dexmedetomidine have been used in functional endoscopic sinus surgery for several outcomes, there is lack in studies that had compared the efficacy of intravenous and Intranasal Dexmedetomidine for improving quality of the operative field in functional endoscopic sinus surgery. Therefore, we established this randomized study to compare intranasal dexmedetomidine with intravenous dexmedetomidine improving quality of the operative field in functional endoscopic sinus surgery.
Timeline
- Start
- 2022-11-10
- Primary completion
- 2023-03-05
- Completion
- 2023-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | Intranasal |
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intranasal |
Indications
No indication recorded.